Stryker opens Neurovascular lab to accelerate stroke-related innovation in Asia Pacific

Stroke is a leading cause of death and disability worldwide, with more than 58 million of those cases recorded in Asia. In India, scarcity of professional care and infrastructure are key factors in the country's treatment rates. This lab offers an ideal environment for medical education, research and development, and customer engagement activities designed to improve patient outcomes.

Read also: Medical device maker Stryker gets US antitrust nod to buy Wright Medical Group

The NV lab has three main components: a neurovascular catheterization lab designed to mimic the hospital treatment experience with the latest imaging and communication equipment; a performance lab with hands-on stations outfitted with flow models, neurovascular simulators, and 3D model printing capabilities; and planned space for physician interaction.

Read also: Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD

Mark O'Brien, Vice President and General Manager for the Neurovascular Division at Stryker, said, "Asia Pacific is our fastest growing region, and a big part of our future growth plans. We are continuing to invest in the region to facilitate innovation and advance stroke care."

Ram Rangarajan, Vice President of Stryker Global Technology Center, said, "We're excited to bring this advanced lab and its capabilities to India's neurointerventionalist community and to help grow the specialty in country. We believe in the concept of public-private partnerships and invite the government to collaborate with us to train future physicians."

Stryker established its first R&D facility in India more than 15 years ago.

Read also: Stryker India MD Meenakshi Nevatia joins APACMed as Chairperson for India Executive Committee